Psychology Today | 22.09.2026 22:58
Ever since the Food and Drug Administration's approval of the first GLP-1 in 2005 and the advent of subsequent formulations, consequences of use have been studied extensively. Science has found that GLP-1 use can have an impact on type-2 diabetes, cardiovascular disease, kidney disease, and some cancers. In addition, they have been implicated in helping individuals to curb alcoholaddiction.
![Era by DJ Zinhle introduces stylish carry-on suitcase [photos]](https://cdn.thefuse.co.za/images2/1/9/c/9/e/19c9e612-654b-319b-abf8-b406318608ae-1200x675.jpg)
